TOUCHPOINT MEDICAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
TOUCHPOINT MEDICAL
NACE 62.100, Computer programming
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€2.2m
2024 · -€7.9m+€5.8m
Equity
€1.7m
2024 · €1.4m+€334,331
Cash
€212,942
2024 · €527,177-€314,235
Balance sheet total
€4.3m
2024 · €6.3m-€1.9m
Largest movements
Assets
- Receivables within one year -€1.5m
down €1.5m (-34.8%), from €4.4m to €2.9m
of which Trade receivables: -€1.5m
- Cash -€314,235
down €314,235 (-59.6%), from €527,177 to €212,942
mainly Net result for the year (-€2.2m) and Trade debts (-€1.6m)
Equity and liabilities
- Contributions +€2.5m
up €2.5m (+22.0%), from €11.4m to €13.9m
- Profit (loss) carried forward -€2.2m
down €2.2m (-21.0%), from -€10.3m to -€12.5m
- Trade debts -€1.6m
down €1.6m (-85.6%), from €1.9m to €273,845
- Advances received -€1.2m
down €1.2m (-77.5%), from €1.6m to €359,481
- Accrued charges and deferred income +€982,866
up €982,866 (+300%), from €328,036 to €1.3m
Income statement
- Turnover -€1.8m
down €1.8m (-26.7%), from €6.7m to €4.9m
- Purchases and services -€1.3m
down €1.3m (-23.2%), from €5.7m to €4.4m
- Gross operating margin -€456,267
down €456,267 (-44.5%), from €1.0m to €568,051
- Staff costs -€427,033
down €427,033 (-14.3%), from €3.0m to €2.6m
- Financial charges -€186,621
down €186,621 (-83.4%), from €223,821 to €37,200
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
-€7.9m
Gross operating margin
-€456,267
Staff costs
+€427,033
Depreciation
+€37,394
Write-downs
-€102,567
Other operating charges
-€47,425
Other operating items
+€5.7m
Financial income
+€6,976
Financial charges
+€186,621
Taxes
+€7,190
Result 2025
-€2.2m
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
-€2.8m
Investment
+€31,996
Financing
+€2.4m
Cash 2024
€527,177
From operations (derived)
-€2.8m
Net result for the year
-€2.2m
Depreciation
+€37,672
Stocks and contracts
+€41,897
Receivables within one year
+€1.5m
Deferred charges and accrued income
-€46,158
Trade debts
-€1.6m
Tax, wage and social debts
+€306,395
Advances received
-€1.2m
Other debts
-€595,989
Accrued charges and deferred income
+€982,866
Investment (derived)
+€31,996
Investment in fixed assets (net)
+€31,996
Financing
+€2.4m
Current portion of long-term debt
-€84,381
Contributions, distributions and other
+€2.5m
Cash 2025
€212,942
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €6,257,150 | €4,338,164 | -€1.9m | -30.7% |
| Fixed assets | 21/28 | €707,270 | €637,602 | -€69,668 | -9.9% |
| Tangible fixed assets | 22/27 | €142,019 | €123,982 | -€18,037 | -12.7% |
| Land and buildings | 22 | €0 | - | = | |
| Plant, machinery and equipment | 23 | €5,262 | - | -€5,262 | |
| Furniture and vehicles | 24 | €18,702 | €23,616 | +€4,914 | +26.3% |
| Other tangible fixed assets | 26 | €118,054 | €100,366 | -€17,689 | -15.0% |
| Financial fixed assets | 28 | €565,251 | €513,620 | -€51,631 | -9.1% |
| Current assets | 29/58 | €5,549,880 | €3,700,562 | -€1.8m | -33.3% |
| Amounts receivable after more than one year | 29 | €0 | - | = | |
| Trade receivables | 290 | €0 | - | = | |
| Stocks and contracts in progress | 3 | €582,217 | €540,320 | -€41,897 | -7.2% |
| Stocks | 30/36 | €582,217 | €540,320 | -€41,897 | -7.2% |
| Amounts receivable within one year | 40/41 | €4,425,313 | €2,885,969 | -€1.5m | -34.8% |
| Trade receivables | 40 | €4,276,672 | €2,769,719 | -€1.5m | -35.2% |
| Other amounts receivable | 41 | €148,642 | €116,250 | -€32,392 | -21.8% |
| Cash at bank and in hand | 54/58 | €527,177 | €212,942 | -€314,235 | -59.6% |
| Deferred charges and accrued income | 490/1 | €15,172 | €61,331 | +€46,158 | +304% |
| Total equity and liabilities | 10/49 | €6,257,150 | €4,338,164 | -€1.9m | -30.7% |
| Equity | 10/15 | €1,389,035 | €1,723,366 | +€334,331 | +24.1% |
| Contributions | 10/11 | €11,359,060 | €13,859,060 | +€2.5m | +22.0% |
| Capital | 10 | €11,359,060 | €13,859,060 | +€2.5m | +22.0% |
| Issued capital | 100 | €11,359,060 | €13,859,060 | +€2.5m | +22.0% |
| Reserves | 13 | €331,939 | €331,939 | = | 0.0% |
| Non-distributable reserves | 130/1 | €37,947 | €37,947 | = | 0.0% |
| Legal reserve | 130 | €35,906 | €35,906 | = | 0.0% |
| Other | 1319 | €2,041 | €2,041 | = | 0.0% |
| Distributable reserves | 133 | €293,992 | €293,992 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€10,301,963 | -€12,467,632 | -€2.2m | -21.0% |
| Amounts payable | 17/49 | €4,868,114 | €2,614,797 | -€2.3m | -46.3% |
| Amounts payable within one year | 42/48 | €4,540,078 | €1,303,895 | -€3.2m | -71.3% |
| Current portion of amounts payable after more than one year | 42 | €84,381 | - | -€84,381 | |
| Trade debts | 44 | €1,897,233 | €273,845 | -€1.6m | -85.6% |
| Suppliers | 440/4 | €1,897,233 | €273,845 | -€1.6m | -85.6% |
| Advances received on contracts in progress | 46 | €1,598,302 | €359,481 | -€1.2m | -77.5% |
| Taxes, remuneration and social security | 45 | €364,174 | €670,569 | +€306,395 | +84.1% |
| Taxes | 450/3 | €44,256 | €309,210 | +€264,954 | +599% |
| Remuneration and social security | 454/9 | €319,918 | €361,359 | +€41,441 | +13.0% |
| Other amounts payable | 47/48 | €595,989 | - | -€595,989 | |
| Accrued charges and deferred income | 492/3 | €328,036 | €1,310,902 | +€982,866 | +300% |
| Turnover | 70 | €6,718,666 | €4,927,886 | -€1.8m | -26.7% |
| Goods, raw materials, services and sundry goods | 60/61 | €5,712,938 | €4,388,546 | -€1.3m | -23.2% |
| Remuneration, social security and pensions | 62 | €2,994,765 | €2,567,732 | -€427,033 | -14.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €75,066 | €37,672 | -€37,394 | -49.8% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€51,574 | €50,994 | +€102,567 | |
| Other operating charges | 640/8 | €11,710 | €59,135 | +€47,425 | +405% |
| Non-recurring operating charges | 66A | €5,704,859 | - | -€5.7m | |
| Gross operating margin | 9900 | €1,024,319 | €568,051 | -€456,267 | -44.5% |
| Operating profit (loss) | 9901 | -€7,710,508 | -€2,147,482 | +€5.6m | +72.1% |
| Financial income | 75/76B | €15,126 | €22,101 | +€6,976 | +46.1% |
| Recurring financial income | 75 | €15,126 | €22,101 | +€6,976 | +46.1% |
| Financial charges | 65/66B | €223,821 | €37,200 | -€186,621 | -83.4% |
| Recurring financial charges | 65 | €223,821 | €37,200 | -€186,621 | -83.4% |
| Profit (loss) for the period before taxes | 9903 | -€7,919,203 | -€2,162,580 | +€5.8m | +72.7% |
| Income taxes | 67/77 | €10,279 | €3,089 | -€7,190 | -69.9% |
| Profit (loss) for the period | 9904 | -€7,929,482 | -€2,165,669 | +€5.8m | +72.7% |
| Profit (loss) for the period to be appropriated | 9905 | -€7,929,482 | -€2,165,669 | +€5.8m | +72.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.